Fumonisins Competitive Antibody Pair

AccuSift
FB
SKU Name Unit Price Delivery QTY
SE067 Fumonisins monoclonal antibody 1mg $667.6 10days
TA048 Fumonisins BSA antigen 1mg $300 10days
AccuSift provides high‑performance fumonisin competitive assay pairings, characterized by exceptional batch‑to‑batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.

Fumonisins are mycotoxins produced by Fusarium verticillioides. They are water‑soluble metabolites, consisting of structurally similar diester compounds formed from different polyhydric alcohols and tricarboxylic acids.
They primarily contaminate grains and their products, cause acute toxicity in some livestock, and exhibit potential carcinogenicity, making them a major research focus after aflatoxins.
On October 27, 2017, the World Health Organization’s International Agency for Research on Cancer (IARC) listed fumonisin B1, Fusarium verticillioidesand its produced toxins (fumonisin B1, fumonisin B2, and fusarin C) as Group 2B carcinogens in its preliminary compilation.
Performance Characteristics:

  • Sensitivity: ELISA IC50: 0.5 ppb; Colloidal Gold: 1 ppb

  • Cross‑Reactivity: FB1 100%; FB2 >80%; FB3 80%

  • Source: Mouse Monoclonal Antibody

  • Purity: ≥ 90%

  • Recommended Pairing: (Coating) / (Labeling)

  • Storage: Long‑term storage at ≤ –20°C; short‑term storage at 2–8°C. Shipped on ice packs.


Operation

References